# INCYTE CORPORATION (INCY) FY2026 YTD Q2 P&L / Income Statement - Company: INCYTE CORPORATION (INCY) - Period: 2026-01-01 to 2026-06-30 - Filing: Q2 FY2026 10-Q, filed 2026-07-28, accession number 0000879169-26-000056 - Page: https://plicit.ai/financials/incy/fy2026-ytd-q2-income-statement - Chart image: https://plicit.ai/charts/incy-fy2026-ytd-q2-income-statement-sankey.png ## Chart details: Revenue by Product and Service by Arrangement Income statement for 2026-01-01 through 2026-06-30. View: Product and Service by Collaborative Arrangement and Arrangement Other than Collaborative. Revenue uses this breakdown; costs and expenses retain the consolidated categories. - **Total revenues**: 2,946,715,000 US dollars - **Cost of sales (including definite-lived intangible amortization)**: 209,480,000 US dollars - **Gross profit (calculated)**: 2,737,235,000 US dollars - **Operating expenses (calculated)**: 1,738,220,000 US dollars - **Income from operations**: 999,015,000 US dollars - **Other income (expense), net (calculated)**: 96,099,000 US dollars - **Income before provision for income taxes**: 1,095,114,000 US dollars - **Provision for income taxes**: 206,179,000 US dollars - **Net income**: 888,935,000 US dollars - **ICLUSIG**: 69,857,000 US dollars - **JAKAFI**: 1,574,414,000 US dollars - **JAKAVI Royalty Revenues**: 229,746,000 US dollars - **MINJUVI/MONJUVI**: 102,913,000 US dollars - **Milestone and contract revenues**: 28,200,000 US dollars - **NIKTIMVO**: 115,397,000 US dollars - **OLUMIANT Royalty Revenues**: 74,886,000 US dollars - **Other**: 8,577,000 US dollars - **PEMAZYRE**: 45,961,000 US dollars - **TABRECTA Royalty Revenues**: 12,673,000 US dollars - **ZYNYZ**: 91,340,000 US dollars - **JAKAVI - Novartis**: 229,700,000 US dollars - **OLUMIANT - Eli Lilly**: 74,900,000 US dollars - **TABRECTA - Novartis**: 12,700,000 US dollars - **Undisclosed (calculated)**: 275,451,000 US dollars - **Research and development**: 1,032,853,000 US dollars - **Selling, general and administrative**: 679,822,000 US dollars - **Asset impairment and related disposal costs**: 23,214,000 US dollars - **Loss on change in fair value of acquisition-related contingent consideration**: 2,331,000 US dollars - **Contract dispute settlement**: 0 US dollars ### Chart connections - Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income. - Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income. ## Chart details: Revenue by Product and Service (12 categories) - Page: https://plicit.ai/financials/incy/fy2026-ytd-q2-income-statement/revenue-by-product-and-service-12-categories - Chart image: https://plicit.ai/charts/incy-fy2026-ytd-q2-revenue-by-product-and-service-12-categories-sankey.png Income statement for 2026-01-01 through 2026-06-30. View: Product and service (12 categories). Revenue uses this breakdown; costs and expenses retain the consolidated categories. - **Total revenues**: 2,946,715,000 US dollars - **Cost of sales (including definite-lived intangible amortization)**: 209,480,000 US dollars - **Gross profit (calculated)**: 2,737,235,000 US dollars - **Operating expenses (calculated)**: 1,738,220,000 US dollars - **Income from operations**: 999,015,000 US dollars - **Other income (expense), net (calculated)**: 96,099,000 US dollars - **Income before provision for income taxes**: 1,095,114,000 US dollars - **Provision for income taxes**: 206,179,000 US dollars - **Net income**: 888,935,000 US dollars - **Milestone and contract revenues**: 28,200,000 US dollars - **JAKAFI**: 1,574,414,000 US dollars - **OPZELURA**: 592,751,000 US dollars - **ICLUSIG**: 69,857,000 US dollars - **PEMAZYRE**: 45,961,000 US dollars - **MINJUVI/MONJUVI**: 102,913,000 US dollars - **NIKTIMVO**: 115,397,000 US dollars - **ZYNYZ**: 91,340,000 US dollars - **JAKAVI Royalty Revenues**: 229,746,000 US dollars - **OLUMIANT Royalty Revenues**: 74,886,000 US dollars - **TABRECTA Royalty Revenues**: 12,673,000 US dollars - **Other**: 8,577,000 US dollars - **Research and development**: 1,032,853,000 US dollars - **Selling, general and administrative**: 679,822,000 US dollars - **Asset impairment and related disposal costs**: 23,214,000 US dollars - **Loss on change in fair value of acquisition-related contingent consideration**: 2,331,000 US dollars - **Contract dispute settlement**: 0 US dollars ### Chart connections - Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income. - Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income. ## Chart details: Revenue by Product and Service (3 categories) - Page: https://plicit.ai/financials/incy/fy2026-ytd-q2-income-statement/revenue-by-product-and-service-3-categories - Chart image: https://plicit.ai/charts/incy-fy2026-ytd-q2-revenue-by-product-and-service-3-categories-sankey.png Income statement for 2026-01-01 through 2026-06-30. View: Product and service (3 categories). Revenue uses this breakdown; costs and expenses retain the consolidated categories. - **Total revenues**: 2,946,715,000 US dollars - **Cost of sales (including definite-lived intangible amortization)**: 209,480,000 US dollars - **Gross profit (calculated)**: 2,737,235,000 US dollars - **Operating expenses (calculated)**: 1,738,220,000 US dollars - **Income from operations**: 999,015,000 US dollars - **Other income (expense), net (calculated)**: 96,099,000 US dollars - **Income before provision for income taxes**: 1,095,114,000 US dollars - **Provision for income taxes**: 206,179,000 US dollars - **Net income**: 888,935,000 US dollars - **Net sales**: 2,592,633,000 US dollars - **Product royalty revenues**: 325,882,000 US dollars - **Milestone and contract revenues**: 28,200,000 US dollars - **Research and development**: 1,032,853,000 US dollars - **Selling, general and administrative**: 679,822,000 US dollars - **Asset impairment and related disposal costs**: 23,214,000 US dollars - **Loss on change in fair value of acquisition-related contingent consideration**: 2,331,000 US dollars - **Contract dispute settlement**: 0 US dollars ### Chart connections - Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income. - Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income. ## Chart details: Revenue by Geography - Page: https://plicit.ai/financials/incy/fy2026-ytd-q2-income-statement/revenue-by-geography - Chart image: https://plicit.ai/charts/incy-fy2026-ytd-q2-revenue-by-geography-sankey.png Income statement for 2026-01-01 through 2026-06-30. View: Geography. Revenue uses this breakdown; costs and expenses retain the consolidated categories. - **Total revenues**: 2,946,715,000 US dollars - **Cost of sales (including definite-lived intangible amortization)**: 209,480,000 US dollars - **Gross profit (calculated)**: 2,737,235,000 US dollars - **Operating expenses (calculated)**: 1,738,220,000 US dollars - **Income from operations**: 999,015,000 US dollars - **Other income (expense), net (calculated)**: 96,099,000 US dollars - **Income before provision for income taxes**: 1,095,114,000 US dollars - **Provision for income taxes**: 206,179,000 US dollars - **Net income**: 888,935,000 US dollars - **UNITED STATES**: 2,731,578,000 US dollars - **Europe**: 197,560,000 US dollars - **Other countries**: 17,577,000 US dollars - **Research and development**: 1,032,853,000 US dollars - **Selling, general and administrative**: 679,822,000 US dollars - **Asset impairment and related disposal costs**: 23,214,000 US dollars - **Loss on change in fair value of acquisition-related contingent consideration**: 2,331,000 US dollars - **Contract dispute settlement**: 0 US dollars ### Chart connections - Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income. - Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.